Table 2 Comparison between baseline and end-of-treatment laboratory investigations among enrolled patients with CHA and HCV

Hb (g/dl)

8.51±1.28

8.4±1.2

p<0.501

Ferritin (ng/ml)

1807.63±1480.36

1762.63±1918.7

p<0.339

T.Bil (mg/dl)

2.62±1.11

2.49±1.48

p<0.542

ALT (IU/l)

54.48±22.9

41.41±24.02

p<0.009

Albumin (g/dl)

4.09±0.48

4.3±0.5

p<0.182

INR

1.17±0.09

1.2±0.14

p<0.341

FIB-4

0.78±0.7

0.61±0.5

p<0.175

APRI

0.44±0.27

0.32±0.22

p<0.046